UCB SA (UCBJF)
OTCMKTS
· Delayed Price · Currency is USD
190.10
0.00 (0.00%)
At close: Mar 25, 2025
UCB SA Revenue
In the year 2024, UCB SA had annual revenue of 6.15B EUR with 18.72% growth. UCB SA had revenue of 3.36B in the half year ending December 31, 2024.
Revenue
6.15B EUR
Revenue Growth
+18.72%
P/S Ratio
n/a
Revenue / Employee
656.00K EUR
Employees
9,378
Market Cap
33.83B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.15B | 970.00M | 18.72% |
| Dec 31, 2023 | 5.18B | -265.00M | -4.87% |
| Dec 31, 2022 | 5.45B | -330.00M | -5.71% |
| Dec 31, 2021 | 5.78B | 430.00M | 8.04% |
| Dec 31, 2020 | 5.35B | 434.00M | 8.83% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.76B |
| SS Innovations International | 16.04M |
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 200.90M |
| Northwest Biotherapeutics | 1.60M |
| Silence Therapeutics | 43.26M |
| American Oncology Network | 1.76B |
UCB SA News
- 24 days ago - Europe-Based UCB's Bimzelx Data Reveals Sustained Skin Clearance In Inflammatory Skin Disorders - Benzinga
- 24 days ago - BIMZELX® (bimekizumab-bkzx) Two-Year Data at AAD Showed Potential to Eliminate Draining Tunnels in Hidradenitis Suppurativa, and Reduction in Disease Burden - Benzinga
- 27 days ago - UCB SA (UCBJF) (Q4 2024) Earnings Call Highlights: Strong Revenue Growth and Strategic ... - GuruFocus
- 27 days ago - Full Year 2024 Ucb SA Earnings Call Transcript - GuruFocus
- 4 weeks ago - Decoding United Community Banks Inc (UCB): A Strategic SWOT Insight - GuruFocus
- 2 months ago - United Community Banks, Inc. (UCB) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - United Community Banks Non-GAAP EPS of $0.63 beats by $0.07, revenue of $239.47M misses by $3.26M - Seeking Alpha
- 2 months ago - UCB Announces U.S. Availability of 320 mg/2 mL Single-Injection Administration Option for BIMZELX® (bimekizumab-bkzx) - Benzinga